Ossium Health
About Ossium Health
Dr. Susannah Cantrell brings more than two decades of experience in biotechnology and pharmaceuticals to her role as Chief Commercial Officer at Ossium Health. She is responsible for leading Ossium’s commercial strategy, go-to-market planning, and partnerships. Dr. Cantrell plays a critical role in driving the company’s platform from development into full-scale commercial availability.
Most recently, Dr. Cantrell served as Chief Business Officer at Brii Biosciences, where she oversaw business development, alliance management, and commercial activities. Prior to Brii Biosciences, Dr. Cantrell served as Chief Business Officer and Chief Operating Officer at Second Genome, where she oversaw the company’s operations, business development, finance, and facilities. Dr. Cantrell also served as Executive Vice President & Chief Commercial Officer at Tricida, where she built a U.S.-focused commercial organization from the ground up.
Dr. Cantrell held senior leadership roles at Gilead Sciences, including Vice President, Global Commercial Strategy & Marketing – Oncology, where she played a key part in growing Gilead’s oncology and inflammation business lines. Earlier in her career, Dr. Cantrell held various global sales and marketing roles at Genentech/Roche and GlaxoSmithKline.
Dr. Cantrell holds a BA in Biology from Westminster College and a PhD in Biochemistry from the University of Missouri-Columbia.